Diagnostic and management of central venous line infections in pediatric cancer patients;Diagnostik und therapie katheter-assoziierter infektionen in der pädiatrischen onkologie

Klinische Padiatrie

Volumn 217, Issue SUPPL. 1, 2005, Pages

  Beutel, K ^a   Simon, Arne ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cancer; Child; Diagnosis and therapy; Intravascular catheter

Indexed keywords

AMIKACIN; AMPHOTERICIN B DEOXYCHOLATE; ANTIINFECTIVE AGENT; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; LINEZOLID; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIMICROBIAL THERAPY; BACTEREMIA; BLOOD FLOW; CANDIDA; CATHETER INFECTION; CHILDHOOD CANCER; ENDOCARDITIS; HUMAN; HYPOTENSION; INFECTION; INTRAVASCULAR CATHETER; NEUTROPHIL; OSTEOMYELITIS; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RELAPSE; REVIEW; STAPHYLOCOCCUS AUREUS; THROMBOSIS;

ANTINEOPLASTIC AGENTS; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CROSS INFECTION; DEVICE REMOVAL; DRUG RESISTANCE, MULTIPLE; HUMANS; NEOPLASMS; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; RISK FACTORS;

EID: 28544444475     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872503     Document Type: Review

References (148)

1. Adamkiewicz TV, Lorenzana A, Doyle J et al. Peripheral vs. central blood cultures in patients admitted to a pediatric oncology ward. Pediatr Infect Dis J 1999; 18: 556-558
2. Aledo A, Heller G, Ren L et al. Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service. J Pediatr Hematol Oncol 1998; 20: 215-221
3. Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 2004; 44: 779-791
4. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003; 36: 1539-1544
5. Anthony TU, Rubin LG. Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob Agents Chemother 1999; 43: 2074-2076
6. Ascher DP, Shoupe BA, Maybee D et al. Persistent catheter-related bacteremia: clearance with antibiotics and urokinase. J Pediatr Surg 1993; 28: 627-629
7. Auletta JJ, O'Riordan MA, Nieder ML. Infections in children with cancer: a continued need for the comprehensive physical examination. J Pediatr Hematol Oncol 1999; 21: 501-508
8. Babu R, Spicer RD. Implanted vascular access devices (ports) in children: complications and their prevention. Pediatr Surg Int 2002; 18: 50-53
9. Bagnall-Reeb H. Evidence for the use of the antibiotic lock technique. J Infus Nurs 2004; 27:118-122
10. Beghetti M, La Scala G, Belli D et al. Etiology and management of pediatric chylothorax. J Pediatr 2000; 136: 653-658
11. Berner R, Sauter S, Michalski Y et al. Central venous catheter infection by Aspergillus fumigatus in a patient with B-type non-Hodgkin lymphoma. Med Pediatr Oncol 1996; 27: 202-204
12. Berner R, Schumacher RF, Bartelt S et al. Predisposing conditions and pathogens in bacteremia in hospitalized children. Eur J Clin Microbiol Infect Dis 1998; 17: 337-340
13. Berrington A, Gould FK. Use of antibiotic locks to treat colonized central venous catheters. J Antimicrob Chemother 2001; 48: 597-603
14. Bestul MB, Vandenbussche HL Antibiotic lock technique: review of the literature. Pharmacotherapy 2005; 25: 211-227
15. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004; 19: 1546-1551
16. Biagi E, Arrigo C, Dell'Orto MG et al. Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies. Support Care Cancer 1997; 5: 228-233
17. Blot F, Nitenberg G, Brun-Buisson C. New tools in diagnosing catheter-related infections. Support Care Cancer 2000; 8: 287-292
18. Blot F, Nitenberg G, Chachaty E et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999; 354:1071-1077
19. Blot F, Schmidt E, Nitenberg G et al. Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998; 36: 105-109
20. Bouza E, Burillo A, Munoz P. Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 2002; 8: 265-274
21. Cairo MS, Spooner S, Sowden L et al. Long-term use of indwelling multipurpose silastic catheters in pediatric cancer patients treated with aggressive chemotherapy. J Clin Oncol 1986; 4: 784-788
22. Capdevila JA, Planes AM, Palomar M et al. Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis 1992; 11: 403-407
23. Carratala J. Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect 2001; 7 (Suppl 4): 83-90
24. Carratala J, Niubo J, Fernandez-Sevilla A et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999; 43: 2200-2204
25. Catton JA, Dobbins BM, Wood JM et al. The routine microbiological screening of central venous catheters in home parenteral nutrition patients. Clin Nutr 2004; 23: 171-175
26. Cesaro S, Corro R, Pelosin A et al. A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol 2004; 83: 183-188
27. Chatzinikolaou I, Hanna H, Hachem R et al. Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study. Diagn Microbiol Infect Dis 2004; 50: 167-172
28. Chatzinikolaou I, Zipf TF, Hanna H et al. Minocycline-ethylenedi- aminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 2003; 36: 116-119
29. Chizuka A, Kami M, Kanda Y et al. Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 577-582
30. Christensen ML, Hancock ML, Gattuso J et al. Parenteral nutrition associated with increased infection rate in children with cancer. Cancer 1993; 72: 2732-2738
31. Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002; 8: 687-693
32. Cohen J, Brun-Buisson C, Torres A et al. Diagnosis of infection in sepsis: an evidence-based review. Crit Care Med 2004; 32: S466-S494
33. Cuntz D, Michaud L, Guimber D et al. Local antibiotic lock for the treatment of infections related to central catheters in parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2002; 26: 104-108
34. Curtin J, Cormican M, Fleming G et al. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 2003; 47: 3145-3148
35. Daghistani D, Horn M, Rodriguez Z et al. Prevention of indwelling central venous catheter sepsis. Med Pediatr Oncol 1996; 26: 405-408
36. Danese PN. Antibiofilm approaches: prevention of catheter colonization. Chem Biol 2002; 9: 873-880
37. Dannenberg C, Bierbach U, Rothe A et al. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol 2003; 25: 616-621
38. Dato VM, Dajani AS. Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr Infect Dis J 1990; 9: 309-314
39. De Sio L, Jenkner A, Milano GM et al. Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients. Pediatr Infect Dis J 2004; 23: 963-965
40. Dettenkofer M.Jonas D, Wiechmann C et al. Effect of skin disinfection with octenidine dihydrochloride on insertion site colonization of intravascular catheters. Infection 2002; 30: 282-285
41. Dillon PW, Jones GR, Bagnall-Reeb HA et al. Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study. J Clin Oncol 2004; 22: 2718-2723
42. Dobbins BM, Kite P, Catton JA et al. In situ endoluminal brushing: a safe technique for the diagnosis of catheter-related bloodstream infection. J Hosp Infect 2004; 58: 233-237
43. Donnell SC, Taylor N, Saene HK van. Translocation cannot be ignored during parenteral nutrition. J Hosp Infect 2004; 56: 246-247
44. Donnell SC, Taylor N, Saene HK van et al. Infection rates in surgical neonates and infants receiving parenteral nutrition: a five-year prospective study. J Hosp Infect 2002; 52: 273-280
45. Droste JC, Jeraj HA, MacDonald A et al. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother 2003; 51: 849-855
46. Eppes SC, Troutman JL, Gutman LT. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr Infect Dis J 1989; 8: 99-104
47. Everts R, Harding H. Catheter-drawn blood cultures: is withdrawing the heparin lock beneficial? Pathology 2004; 36: 170-173
48. Fatkenheuer G, Buchheidt D, Comely OA et al. Central venous catheter (CVC)-related infections in neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003; 82 (Suppl 2): S149-S157
49. Fatkenheuer G, Comely O, Seifert H. Clinical management of catheter-related infections. Clin Microbiol Infect 2002; 8: 545-550
50. Fleischhack G, Hartmann C, Simon A et al. Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer. J Antimicrob Chemother 2001; 47: 841-853
51. Fleischhack G, Schmidt-Niemann M, Wulff B et al. Piperacillin, betalactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients. Support Care Cancer 2001; 9: 372-379
52. Flynn PM, Shenep JL, Stokes DC et al. In situ management of confirmed central venous catheter-related bacteremia. Pediatr Infect Dis J 1987; 6: 729-734
53. Franklin JA, Gaur AH, Shenep JL et al. In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood culture. Pediatr Infect Dis J 2004; 23: 614-618
54. Fratino G, Molinari AC, Parodi S et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol 2005; 16: 648-654
55. Friedman ND, Korman TM, Fairley CK et al. Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. J Infect 2002; 45: 47-53
56. Fukunaga A, Naritaka H, Fukaya R et al. Povidone-iodine ointment and gauze dressings associated with reduced catheter-related infection in seriously ill neurosurgical patients. Infect Control Hosp Epidemiol 2004; 25: 696-698
57. Gassas A, Grant R, Richardson S et al. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients. J Clin Oncol 2004; 22: 1222-1227
58. Gaur AH, Flynn PM, Giannini MA et al. Difference in time to detection: a simple method to differentiate catheter-related from noncatheter-related bloodstream infection in immunocompromised pediatric patients. Clin Infect Dis 2003; 37: 469-475
59. Gaur AH, Giannini MA, Flynn PM et al. Optimizing blood culture practices in pediatric immunocompromised patients: evaluation of media types and blood culture volume. Pediatr Infect Dis J 2003; 22: 545-552
60. Gorelick MH, Owen WC, Seibel NL et al. Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatr Infect Dis J 1991; 10: 506-510
61. Graninger W, Assadian O, Lagler H et al. The role of glycopeptides in the treatment of intravascular catheter-related infections. Clin Microbiol Infect 2002; 8: 310-315
62. Guedon C, Nouvellon M, Lalaude O et al. Efficacy of antibiotic-lock technique with teicoplanin in staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 2002; 26: 109-113
63. Guggenbichler JP, Berchtold D, Allerberger F et al. In vitro and in vivo effect of antibiotics on catheters colonized by staphylococci. Eur J Clin Microbiol Infect Dis 1992; 11: 408-415
64. Hachem R, Raad I. Prevention and management of long-term catheter related infections in cancer patients. Cancer Invest 2002; 20: 1105-1113
65. Haimi-Cohen Y, Husain N, Meenan J et al. Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique. Antimicrob Agents Chemother 2001; 45: 1565-1567
66. Haimi-Cohen Y, Shafinoori S, Tucci V et al. Use of incubation time to detection in BACTEC 9240 to distinguish coagulase-negative staphylococcal contamination from infection in pediatric blood cultures. Pediatr Infect Dis J 2003; 22: 968-974
67. Haimi-Cohen Y, Vellozzi EM, Rubin LG. Initial concentration of Staphylococcus epidermidis in simulated pediatric blood cultures correlates with time to positive results with the automated, continuously monitored BACTEC blood culture system. J Clin Microbiol 2002; 40: 898-901
68. Hanna H, Afif C, Alakech B et al. Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 2004; 25: 646-649
69. Henrickson KJ, Axtell RA, Hoover SM et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18:1269-1278
70. Isaacman DJ, Karasic RB, Reynolds EA et al. Effect of number of blood cultures and volume of blood on detection of bacteremia in children. J Pediatr 1996; 128:190-195
71. Johnston D, Phillips G, Perry M et al. Taurolin for the prevention of parenetral nutrition related infection: antimicrobial activity and long-term use. Clinical Nutrition 1993; 12: 365-368
72. Jones GR, Konsler GK, Dunaway RP. Urokinase in the treatment of bacteremia and candidemia in patients with right atrial catheters. Am J Infect Control 1996; 24: 160-166
73. Jones GR, Konsler GK, Dunaway RP et al. Prospective analysis of urokinase in the treatment of catheter sepsis in pediatric hematology-oncology patients. J Pediatr Surg 1993; 28: 350-355
74. Journeycake JM, Buchanan GR. Thrombotic complications of central venous catheters in children. Curr Opin Hematol 2003; 10: 369-374
75. Jurewitsch B, Lee T, Park J et al. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related blood-stream infections. JPEN J Parenter Enterai Nutr 1998; 22: 242-244
76. Kalmanti M, Germanakis J, Stiakaki E et al. Prophylaxis with urokinase in pediatric oncology patients with central venous catheters. Pediatr Hematol Oncol 2002; 19: 173-179
77. Kellerman S, Chan J, Jarvis W. Use of urokinase in pediatric hematology/oncology patients. Am J Infect Control 1998; 26: 502-506
78. Kennedy HF, Morrison D, Tomlinson D et al. Gingivitis and toothbrushes: potential roles in viridans streptococcal bacteraemia. J Infect 2003; 46: 67-70
79. Kim DH, Bae NY, Sung WJ et al. Hickman catheter site infections after allogeneic stem cell transplantation: a single-center experience. Transplant Proc 2004; 36: 1569-1573
80. Kim SH, Kang CI, Kim HB et al. Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2003; 24: 897-904
81. Kite P, Dobbins BM, Wilcox MH et al. Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal. Lancet 1999; 354: 1504-1507
82. Koldehoff M, Zakrzewski JL Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents 2004; 24: 491-495
83. Kramer A, Daeschlein G, Kammerlander G et al. Consensus recommendation for the choice of antiseptic agents in wound care (Article in German). Hygiene und Medizin 2004; 29:147-157
84. La Quaglia MP, Lucas A, Thaler HT et al. A prospective analysis of vascular access device-related infections in children. J Pediatr Surg 1992; 27:840-842
85. Laws H, Göbel U, Christaras A et al. Intensivierte Chelattherapie bei Patienten mit Thalassemia major. Klin Pädiatr 2005; 217:120-125
86. Lee CS, Hwang B, Chung RL et al. The assessment of anaerobic blood culture in children. J Microbiol Immunol Infect 2000; 33: 49-52
87. Levy I, Rubin LG, Vasishtha S et al. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 1998; 26: 1086-1088
88. Longuet P, Douard MC, Ariel G et al. Venous access port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. Clin Infect Dis 2001; 32: 1776-1783
89. McCarthy A, Rao JS, Byrne M et al. Central venous catheter infections treated with teicoplanin. Eur J Haematol Suppl 1998; 62: 15-17
90. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003; 348: 1123-1133
91. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132: 391-402
92. Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs 2001; 24: 180-205
93. Messing B, Peitra-Cohen S, Debure A et al. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Patenter Enteral Nutr 1988; 12: 185-189
94. Mirro Jr J, Rao BN, Kumar M et al. A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. J Pediatr Surg 1990; 25: 120-124
95. Mirro Jr J, Rao BN, Stokes DC et al. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 1989; 7: 214-222
96. Molinari AC, Castagnola E, Mazzola C et al. Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: a retrospective study of 362 catheters. Support Care Cancer 2001; 9: 539-544
97. Molinari AC, Haupt R, Saracco P et al. Urokinase for restoring patency of malfunctioning or blocked central venous catheters in children with hemato-oncological diseases. Support Care Cancer 2004; 12: 840-843
98. Monzon M, Oteiza C, Leiva J et al. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 2001; 48: 793-801
99. Monzon M, Oteiza C, Leiva J et al. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagn Microbiol Infect Dis 2002; 44: 319-324
100. Morrison VA, Peterson BA, Bloomfield CD. Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia, and type of malignancy. Med Pediatr Oncol 1990; 18: 209-216
101. Mullen CA, Abd El-Baki H, Samir H et al. Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients. Support Care Cancer 2003; 11: 321-325
102. Nace CS, Ingle RJ. Central venous catheter "pinch-off" and fracture: a review of two under-recognized complications. Oncol Nurs Forum 1993;20:1227-1236
103. Nouwen JL, Belkum A van, de Marie S et al. Clonal expansion of Staphylococcus epidermidis strains causing Hickman catheter-related infections in a hemato-oncologic department. J Clin Microbiol 1998; 36: 2696-2702
104. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 23: 759-769
105. Pappas PG, Rex JH, Sobel JD et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38:161-189
106. Posteraro B, Bruno S, Boccia S et al. Candida parapsilosis bloodstream infection in pediatric oncology patients: results of an epidemiologic investigation. Infect Control Hosp Epidemiol 2004; 25: 641-645
107. Raad II, Luna M, Khalil SA et al. The relationship between the thrombotic and infectious complications of central venous catheters. Jama 1994; 271: 1014-1016
108. Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis 1992; 14: 75-82
109. Raad II, Vartivarian S, Khan A et al. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991; 13: 1120-1125
110. Raad I. Intravascular-catheter-related infections. Lancet 1998; 351: 893-898
111. Raad I. Management of intravascular catheter-related infections. J Antimicrob Chemother 2000; 45: 267-270
112. Raad I, Buzaid A, Rhyne J et al. Minocycline and ethylenediamine- tetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 1997; 25: 149-151
113. Raad I, Chatzinikolaou I, Chaiban G et al. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 2003; 47: 3580-3585
114. Raad I, Hachem R, Tcholakian RK et al. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 2002; 46: 327-332
115. Raad I, Hanna HA, Alakech B et al. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004; 140: 18-25
116. Raad I, Narro J, Khan A et al. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis 1992; 11: 675-682
117. Rackoff WR, GeJ, Sather HN et al. Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol 1999; 21: 260-267
118. Raucher HS, Hyatt AC, Barzilai A et al. Quantitative blood cultures in the evaluation of septicemia in children with Broviac catheters. J Pediatr 1984; 104: 29-33
119. Rijnders BJ, Wijngaerden E Van, Vandecasteele SJ et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 2005; 55: 90-94
120. Robinson JL Sensitivity of a blood culture drawn through a single lumen of a multilumen, long-term, indwelling, central venous catheter in pediatric oncology patients. J Pediatr Hematol Oncol 2002; 24: 72-74
121. Rubin LG, Shih S, Shende A et al. Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal. Clin Infect Dis 1999; 29: 102-105
122. Safdar N, Fine JP, Maki DG. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 2005; 142: 451-466
123. Salzer W, Steinberg SM, Liewehr DJ et al. Evaluation and treatment of fever in the non-neutropenic child with cancer. J Pediatr Hematol Oncol 2003; 25: 606-612
124. Salzman MB, Rubin LG. Intravenous catheter-related infections. Adv Pediatr Infect Dis 1995; 10: 337-368
125. Salzman MB, Rubin LG. Relevance of the catheter hub as a portal for microorganisms causing catheter-related bloodstream infections. Nutrition 1997; 13: 15S-17S
126. Seifert H, Comely O, Seggewiss K et al. Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresis.J Clin Microbiol 2003; 41: 118-123
127. Shah CB, Mittelman MW, Costerton JW et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 2002; 46: 1674-1679
128. Shankar KR, Abernethy LJ, Das KS et al. Magnetic resonance venography in assessing venous patency after multiple venous catheters. J Pediatr Surg 2002; 37: 175-179
129. Shulman RJ, Phillips S, Laine L et al. Volume of blood required to obtain central venous catheter blood cultures in infants and children. JPENJ Parenter Enterai Nutr 1993; 17: 177-179
130. Siegman-Igra Y, Anglim AM, Shapiro DE et al. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol 1997; 35: 928-936
131. Simon A, Fleischhack G. [Surveillance for nosocomial infections in pediatric hematology/oncology patients]. Klin Padiatr 2001; 213 (Suppl 1): A106-A113
132. Simon A, Fleischhack G, Hasan C et al. Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 2000; 21: 592-596
133. Simon A, Gröger N, Engelhart S et al. Vancomycin-resistente Enterokokken [VRE]. Übersicht zu Bedeutung, Prävention und Management in der Pädiatrie. Hygiene und Medizin 2004; 29: 259-275
134. Simon A, Schaaf F, Marklein G et al. Methicillin-resistente Staphylococcus aureus [MRSA]. Übersicht zu Bedeutung und Management in der stationären Kinderheilkunde. Hygiene und Medizin 2003; 28: 62-74
135. Singh-Naz N, Sleemi A, Pikis A et al. Vancomycin-resistant Enterococcus faecium colonization in children. J Clin Microbiol 1999; 37: 413-416
136. Sitges-Serra A, Girvent M. Catheter-related bloodstream infections. World J Surg 1999; 23: 589-595
137. Skladal D, Horak E, Maurer K et al. Complications of percutaneous insertion of Hickman catheters in children. J Pediatr Surg 1999; 34: 1510-1513
138. Smith TL, Pullen GT, Crouse V et al. Bloodstream infections in pediatric oncology outpatients: a new healthcare systems challenge. Infect Control Hosp Epidemiol 2002; 23: 239-243
139. Sofka K, Wiszniewsky G, Blaser G et al. Antibakterieller Honig (Medihoney™) zur Wundpflege. Wundantisepsis bei pädiatrischen Patienten in der Hämatologie-Onkologie? Krankenhaushygiene und Infektionsverhütung 2004; 26: 183-187
140. Torres-Viera C, Thauvin-Eliopoulos C, Souli M et al. Activities of taurolidine in vitro and in experimental enterococcal endocarditis. Antimicrob Agents Chemother 2000; 44: 1720-1724
141. Traub WH, Leonhard B, Bauer D. Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. Chemotherapy 1993; 39: 322-330
142. Trautmann M, Krier C. Katheterinfektionen - Prävention, Diagnose und Management von Infektionen durch intravasale Katheter. 1. Aufl. Thieme Verlag, Stuttgart 2004
143. Tunkel AR. Adjunctive Dexamethasone in Bacterial Meningitis in Children. Curr Infect Dis Rep 2003; 5: 319
144. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 2002; 34: 1524-1529
145. Hoff J van, Berg AT, Seashore JH. The effect of right atrial catheters on infectious complications of chemotherapy in children. J Clin Oncol 1990; 8: 1255-1262
146. Viale P, Pagani L, Petrosillo N et al. Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. J Chemother 2003; 15: 152-156
147. Weisman LE. Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patient. Curr Opin Infect Dis 2004; 17:237-241
148. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999; 29: 490-494